• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断阿尔茨海默病:经济评估的系统综述。

Diagnosing Alzheimer's disease: a systematic review of economic evaluations.

机构信息

Alzheimer Centre Limburg, School for Mental Health and Neuroscience, University Medical Centre, Maastricht, The Netherlands.

Alzheimer Centre Limburg, School for Mental Health and Neuroscience, University Medical Centre, Maastricht, The Netherlands.

出版信息

Alzheimers Dement. 2014 Mar;10(2):225-37. doi: 10.1016/j.jalz.2013.02.005. Epub 2013 May 30.

DOI:10.1016/j.jalz.2013.02.005
PMID:23727080
Abstract

BACKGROUND

The objective of this study is to systematically review the literature on economic evaluations of interventions for the early diagnosis of Alzheimer's disease (AD) and related disorders and to describe their general and methodological characteristics. We focused on the diagnostic aspects of the decision models to assess the applicability of existing decision models for the evaluation of the recently revised diagnostic research criteria for AD.

METHODS

PubMed and the National Institute for Health Research Economic Evaluation database were searched for English-language publications related to economic evaluations on diagnostic technologies. Trial-based economic evaluations were assessed using the Consensus on Health Economic Criteria list. Modeling studies were assessed using the framework for quality assessment of decision-analytic models.

RESULTS

The search retrieved 2109 items, from which eight decision-analytic modeling studies and one trial-based economic evaluation met all eligibility criteria.

CONCLUSIONS

Diversity among the study objective and characteristics was considerable and, despite considerable methodological quality, several flaws were indicated. Recommendations were focused on diagnostic aspects and the applicability of existing models for the evaluation of recently revised diagnostic research criteria for AD.

摘要

背景

本研究旨在系统综述有关阿尔茨海默病(AD)及相关疾病早期诊断干预措施的经济学评价文献,并描述其一般特征和方法学特征。我们重点关注决策模型的诊断方面,以评估现有决策模型在评估最近修订的 AD 诊断研究标准中的适用性。

方法

检索了 PubMed 和英国国家卫生研究院经济评价数据库中有关诊断技术经济学评价的英文文献。采用共识健康经济标准清单评估基于试验的经济学评价,采用决策分析模型质量评估框架评估建模研究。

结果

检索到 2109 项研究,其中 8 项决策分析模型研究和 1 项基于试验的经济学评价符合所有纳入标准。

结论

研究目的和特征的多样性非常大,尽管方法学质量较高,但也存在一些缺陷。建议侧重于诊断方面以及现有模型在评估最近修订的 AD 诊断研究标准中的适用性。

相似文献

1
Diagnosing Alzheimer's disease: a systematic review of economic evaluations.诊断阿尔茨海默病:经济评估的系统综述。
Alzheimers Dement. 2014 Mar;10(2):225-37. doi: 10.1016/j.jalz.2013.02.005. Epub 2013 May 30.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.多奈哌齐、卡巴拉汀和加兰他敏治疗阿尔茨海默病的临床疗效及成本效益:一项快速系统评价
Health Technol Assess. 2001;5(1):1-137. doi: 10.3310/hta5010.
4
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.基于模型的阿尔茨海默病治疗经济评估的系统评价
Pharmacoeconomics. 2016 Jul;34(7):681-707. doi: 10.1007/s40273-016-0392-1.
5
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.多奈哌齐、加兰他敏、利伐斯的明和美金刚治疗阿尔茨海默病的有效性和成本效果(技术评估第 111 号回顾):系统评价和经济模型。
Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.
6
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.基于家庭的、由护士主导的老年人健康促进的临床效果和成本效益:系统评价。
Health Technol Assess. 2012;16(20):1-72. doi: 10.3310/hta16200.
7
Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses.阿尔茨海默病患者治疗方案的经济评价:成本效益分析的系统评价。
Drugs. 2012 Apr 16;72(6):789-802. doi: 10.2165/11631830-000000000-00000.
8
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
9
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在结直肠癌术前分期中的价值:系统评价和经济评估。
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
10
Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.阿尔茨海默病疾病进展建模:用于成本效益分析的建模方法综述
Pharmacoeconomics. 2007;25(9):735-50. doi: 10.2165/00019053-200725090-00003.

引用本文的文献

1
Cognitive impairment screening strategy to reduce the burden of Alzheimer's disease in Shanghai: A system dynamics approach.减轻上海阿尔茨海默病负担的认知障碍筛查策略:一种系统动力学方法。
J Alzheimers Dis Rep. 2025 May 4;9:25424823251337941. doi: 10.1177/25424823251337941. eCollection 2025 Jan-Dec.
2
Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.在临床环境中使用抗淀粉样蛋白疗法诊断和治疗早期阿尔茨海默病患者的成本效益。
J Alzheimers Dis. 2025 Apr;104(4):1167-1184. doi: 10.1177/13872877251323231. Epub 2025 Mar 20.
3
Nucleic acid aptamer-based electrochemical sensor for the detection of serum P-tau231 and the instant screening test of Alzheimer's disease.
基于核酸适体的电化学传感器用于检测血清 P-tau231 及阿尔茨海默病的即时筛查测试。
Mikrochim Acta. 2024 May 14;191(6):328. doi: 10.1007/s00604-024-06395-0.
4
Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease.3-羟基-3-甲基戊二酰辅酶 A 还原酶在阿尔茨海默病中的作用机制。
Int J Mol Sci. 2023 Dec 22;25(1):170. doi: 10.3390/ijms25010170.
5
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target.TREM2 在 AD 发病机制中的作用:一个脂质代谢调节剂和潜在的代谢治疗靶点。
Mol Neurodegener. 2022 Jun 3;17(1):40. doi: 10.1186/s13024-022-00542-y.
6
The Effects of Social Activities and Living Arrangements on Cognitive Functions in Middle-aged and Elderly Adults: A Panel Study Using the 2006-2018 Korean Longitudinal Study of Aging.社交活动和生活安排对中年和老年人认知功能的影响:基于 2006-2018 年韩国老龄化纵向研究的面板研究
J Prev Med Public Health. 2021 Nov;54(6):395-403. doi: 10.3961/jpmph.21.384. Epub 2021 Oct 22.
7
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment.CCCDTD5:神经影像学和液体生物标志物在认知障碍患者中的临床作用
Alzheimers Dement (N Y). 2021 Jan 22;6(1):e12098. doi: 10.1002/trc2.12098. eCollection 2020.
8
A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.基于机器学习的语言电池,用于诊断阿尔茨海默病导致的轻度认知障碍。
PLoS One. 2020 Mar 5;15(3):e0229460. doi: 10.1371/journal.pone.0229460. eCollection 2020.
9
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients.为轻度认知障碍阿尔茨海默病患者引入诊断方法的经济影响。
Alzheimers Dement (N Y). 2019 Aug 16;5:382-387. doi: 10.1016/j.trci.2019.06.001. eCollection 2019.
10
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.评估阿尔茨海默病早期干预的成本效益:一个开源建模框架。
Alzheimers Dement. 2019 Oct;15(10):1309-1321. doi: 10.1016/j.jalz.2019.05.004. Epub 2019 Aug 8.